| Radhika Chandramouli, MD | |
|
6451 Village Ln, Macungie, PA 18062-8484 | |
| (610) 967-2772 | |
| (610) 967-2599 |
| Full Name | Radhika Chandramouli |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 8 Years |
| Location | 6451 Village Ln, Macungie, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386099968 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD466719 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lehigh Valley Hospital | Allentown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lehigh Valley Physician Group | 3072425123 | 1763 |
News Archive
Origin Agritech Limited ("Origin" or the "Company") today announced that it completed its Second Notes Repurchase Agreement (the "Agreement") as of December 30, 2009 with Citadel Equity Fund Ltd. ("Citadel") of the remaining portion of the Company's outstanding 1% Guaranteed Senior Secured Convertible Notes due 2012 (the "Notes") by full repayment in cash of the agreed upon purchase price due to Citadel.
Impairment of oral intake occurs in the majority of patients with head and neck cancer (HNC) receiving chemoradiotherapy. Placement of prophylactic percutaneous endoscopic gastrostomy (PEG) tube in asymptomatic newly diagnosed HNC before chemoradiation is a common practice in some centers. In some studies, PEG has been associated with a decrease in treatment related weight loss in patients with HNC, but no studies have examined the utilization rate.
AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, announced the issuance of patents in the US and Europe that provide additional coverage for its SHM-XEL platform. These patents extend AnaptysBio's leadership in the use of somatic hypermutation (SHM) for the discovery and optimization of antibodies and other proteins.
Reuters reports that the health care sector will be "a focal point" for years to come and looks at investments in companies that are likely to make money by helping to reduce costs. Meanwhile, Kaiser Health News examines whether competitive health care models like Medicare Part D and the Federal Employees Health Benefits program are taming costs as effectively as supporters suggest.
› Verified 2 days ago
| Entity Name | Lehigh Valley Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
Origin Agritech Limited ("Origin" or the "Company") today announced that it completed its Second Notes Repurchase Agreement (the "Agreement") as of December 30, 2009 with Citadel Equity Fund Ltd. ("Citadel") of the remaining portion of the Company's outstanding 1% Guaranteed Senior Secured Convertible Notes due 2012 (the "Notes") by full repayment in cash of the agreed upon purchase price due to Citadel.
Impairment of oral intake occurs in the majority of patients with head and neck cancer (HNC) receiving chemoradiotherapy. Placement of prophylactic percutaneous endoscopic gastrostomy (PEG) tube in asymptomatic newly diagnosed HNC before chemoradiation is a common practice in some centers. In some studies, PEG has been associated with a decrease in treatment related weight loss in patients with HNC, but no studies have examined the utilization rate.
AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, announced the issuance of patents in the US and Europe that provide additional coverage for its SHM-XEL platform. These patents extend AnaptysBio's leadership in the use of somatic hypermutation (SHM) for the discovery and optimization of antibodies and other proteins.
Reuters reports that the health care sector will be "a focal point" for years to come and looks at investments in companies that are likely to make money by helping to reduce costs. Meanwhile, Kaiser Health News examines whether competitive health care models like Medicare Part D and the Federal Employees Health Benefits program are taming costs as effectively as supporters suggest.
› Verified 2 days ago
| Entity Name | Schuylkill Health System Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588603567 PECOS PAC ID: 0840285532 Enrollment ID: O20040420001197 |
News Archive
Origin Agritech Limited ("Origin" or the "Company") today announced that it completed its Second Notes Repurchase Agreement (the "Agreement") as of December 30, 2009 with Citadel Equity Fund Ltd. ("Citadel") of the remaining portion of the Company's outstanding 1% Guaranteed Senior Secured Convertible Notes due 2012 (the "Notes") by full repayment in cash of the agreed upon purchase price due to Citadel.
Impairment of oral intake occurs in the majority of patients with head and neck cancer (HNC) receiving chemoradiotherapy. Placement of prophylactic percutaneous endoscopic gastrostomy (PEG) tube in asymptomatic newly diagnosed HNC before chemoradiation is a common practice in some centers. In some studies, PEG has been associated with a decrease in treatment related weight loss in patients with HNC, but no studies have examined the utilization rate.
AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, announced the issuance of patents in the US and Europe that provide additional coverage for its SHM-XEL platform. These patents extend AnaptysBio's leadership in the use of somatic hypermutation (SHM) for the discovery and optimization of antibodies and other proteins.
Reuters reports that the health care sector will be "a focal point" for years to come and looks at investments in companies that are likely to make money by helping to reduce costs. Meanwhile, Kaiser Health News examines whether competitive health care models like Medicare Part D and the Federal Employees Health Benefits program are taming costs as effectively as supporters suggest.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Radhika Chandramouli, MD Po Box 783311, Philadelphia, PA 19178-3311 Ph: (484) 884-4500 | Radhika Chandramouli, MD 6451 Village Ln, Macungie, PA 18062-8484 Ph: (610) 967-2772 |
News Archive
Origin Agritech Limited ("Origin" or the "Company") today announced that it completed its Second Notes Repurchase Agreement (the "Agreement") as of December 30, 2009 with Citadel Equity Fund Ltd. ("Citadel") of the remaining portion of the Company's outstanding 1% Guaranteed Senior Secured Convertible Notes due 2012 (the "Notes") by full repayment in cash of the agreed upon purchase price due to Citadel.
Impairment of oral intake occurs in the majority of patients with head and neck cancer (HNC) receiving chemoradiotherapy. Placement of prophylactic percutaneous endoscopic gastrostomy (PEG) tube in asymptomatic newly diagnosed HNC before chemoradiation is a common practice in some centers. In some studies, PEG has been associated with a decrease in treatment related weight loss in patients with HNC, but no studies have examined the utilization rate.
AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, announced the issuance of patents in the US and Europe that provide additional coverage for its SHM-XEL platform. These patents extend AnaptysBio's leadership in the use of somatic hypermutation (SHM) for the discovery and optimization of antibodies and other proteins.
Reuters reports that the health care sector will be "a focal point" for years to come and looks at investments in companies that are likely to make money by helping to reduce costs. Meanwhile, Kaiser Health News examines whether competitive health care models like Medicare Part D and the Federal Employees Health Benefits program are taming costs as effectively as supporters suggest.
› Verified 2 days ago
John Bessada, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 6451 Village Ln, Macungie, PA 18062 Phone: 610-967-2772 | |
Dr. Lindsay Rae Pereira, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6451 Village Ln, Macungie, PA 18062 Phone: 610-967-2772 Fax: 610-967-2599 | |
Fariba Kharazi, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2550 Pa Route 100, Suite 220, Macungie, PA 18062 Phone: 610-628-7111 Fax: 833-820-1003 | |
Dr. Yasir Hani Abunamous, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6451 Village Ln, Macungie, PA 18062 Phone: 610-967-0127 Fax: 610-967-2559 | |
Dr. Deanna Ligenza, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6887 Sunflower Lane, Macungie, PA 18062 Phone: 610-421-8235 | |
William Joseph Liaw, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3760 Brookside Rd, Macungie, PA 18062 Phone: 610-628-7111 Fax: 610-628-7180 |